Not all Senescent Cells are Equal
Thumbnail from YouTube. Playing loads the YouTube player.
History & recommendationsOff
Keep recently viewed content on this browser. Your history stays on this device and is never sent to Harbor. Videos you play can also help order related video recommendations.
Open saved items & history →About this video
Creator description · original language
The link to the preprint: https://www.biorxiv.org/content/10.1101/2025.08.27.672709v1.full.pdf
Key-words: 1:2:3:4 punch, Adipose tissue, Aging, Apoptosis, Cancer, Cellular senescence, Chemotherapy, CyTOF, Dasatinib, Endothelial cells, Fibrosis, Frailty, GPNMB, HUVECs, Immune cells, Inflammation, JAK/STAT inhibitor, Lipopolysaccharide (LPS), Macrophages, Mass cytometry, Mice, mtDNA, Natural killer (NK) cells, Obesity, p16INK4a, p21CIP1, PAMPs, Physical dysfunction, Preadipocytes, Proliferative arrest, Quercetin, RNA sequencing, Ruxolitinib, SAβgal, SASP, SCAPs, SCID-beige mice, Senescent cell (SC), Senescent cell anti-apoptotic pathways, Senescence-associated secretory phenotype, Senolytics, Senolytic-resistant, Senolytic-sensitive, Senomorphics, Senosensitizers, Therapy-induced senescence (TIS), TLR3 agonist, Transplantation, Triple-negative breast cancer (TNBC), γH2AX
The Sanz Science Experience · 5 min · Source published: 2025-09-05
Added to Harbor: 10/22/2026
Original on YouTube ↗Automatically categorized source. Creator statements are not an independent evidence review or personal medical guidance.